COVID-19 Test At Home Feasibility Sub-Study

The purpose of this feasibility study is to gather knowledge that will inform a future larger study using at-home SARS-CoV-2 testing and digital tools. This study will: 1) Test the feasibility of daily home SARS-CoV-2 testing using the the Quidel QuickVue device; 2) Test whether a smartphone app (CareEvolution MyDataHelps) designed to support at-home testing is acceptable and usable; and 3)Examine other key process metrics and variables important to the design of a larger randomized trial. In particular, the feasibility of the Quidel Quickview home test and the digital app will be assessed through data on the number of home SARS-CoV-2 tests performed and number of home SARS-CoV-2 tests transmitted through the mobile health app. Secondary outcomes of importance are: (1)participant self-reported overall usability of the app-supported at-home testing system; (2) participant self-reported acceptability of the at-home test and smartphone app using the net promoter scale; (3) participant self-reported quality of the CareEvolution MyDataHelps app will be using the uMARS (Mobile app rating scale); and (4) concordance between self-interpretation and study-team interpretation of self-test SARS-CoV-2 results. This is a feasibility study that enrolled an observational cohort into an intervention only arm of future cluster RCT.